Unknown

Dataset Information

0

Certolizumab pegol for induction of remission in Crohn's disease

ABSTRACT: Abstract This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objectives of this systematic review are to evaluate the efficacy and safety of CZP for induction of remission in CD.

SUBMITTER: Yamazaki H 

PROVIDER: S-EPMC6486011 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Certolizumab pegol for induction of remission in Crohn's disease.
| S-EPMC6718195 | biostudies-literature
Unknown Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease.
| S-EPMC5765392 | biostudies-literature
Unknown Population pharmacokinetic analysis of certolizumab pegol in patients with Crohn's disease.
| S-EPMC6680228 | biostudies-literature
Unknown Patient adherence and efficacy of certolizumab pegol in the management of Crohn's disease.
| S-EPMC3987757 | biostudies-literature
Unknown Certolizumab pegol.
| S-EPMC2840232 | biostudies-literature
Unknown Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE.
| S-EPMC7410911 | biostudies-literature
Unknown Adalimumab for induction of remission in Crohn's disease.
| S-EPMC6953260 | biostudies-literature
Unknown Probiotics for induction of remission in Crohn's disease.
| S-EPMC7389339 | biostudies-literature
Unknown Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction.
| S-EPMC7307216 | biostudies-literature
Unknown Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
| S-EPMC4949014 | biostudies-literature